The Research and Development team at the Josep Carreras Leukaemia Research Institute focuses on advancing scientific knowledge and developing innovative therapies for leukaemia, lymphoma, and related blood disorders. This multidisciplinary team collaborates on experimental research, manages animal models, and utilizes advanced proteomic techniques to identify potential treatment targets, all aimed at enhancing patient outcomes and advancing the field of hematology.